ABT · 8-K · 20261021PR117587

Revenue Performance and Mix

ABBOTT LABORATORIES · 2026-10-21 · Importance 64 · Surprise 42 · Contradicted

The Nutrition business generates approximately $8.5 billion in annual sales and will operate as a standalone healthy-nutrition company after the separation. Abbott expects to retain approximately $42 billion of sales after the transaction, with its portfolio focused on cardiovascular and neuromodulation devices, biowearables, diagnostics and established medicines. The separation therefore removes Nutrition sales representing roughly 17% of Abbott’s stated post-transaction-plus-Nutrition sales profile, based on the disclosed $8.5 billion and $42 billion figures. Nutrition will serve developed and emerging markets across infant, pediatric, medical and adult nutrition categories.

Key facts

• After the transaction, Abbott will have sales of approximately $42 billion. source
• The new Nutrition company will have approximately $8.5 billion in annual sales. source
• Abbott’s 122,000 colleagues serve people in more than 160 countries. source

Impact estimates